Uncategorised - European Medical Journal

Continue
EMJ
22 May 2015

Data Presented on Orsiro Hybrid Drug – El uting Stent at EuroPCR 2015 Highlights Safety and Efficacy in High – Risk Patients

PARIS, France, May 20, 2015—BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, today hosted a…
EMJ
21 May 2015

PARP inhibitors and the EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg…
EMJ
21 May 2015

The mechanisms of BRCA-related breast cancer and molecular profiling

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof…
EMJ
21 May 2015

Current research into treatments for BRCA-related breast cancer and the phase 3 EMBRACA trial

Dr Kelly focuses on the phase 3 EMBRACA study, which is evaluating the PARP inhibitor, talazoparib, versus physician’s choice in patients with locally advanced and/or metastatic BRCA-related breast cancer.
EMJ
21 May 2015

The role of BRCA and PARP in DNA repair and BRCA-related breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg…
EMJ
21 May 2015

The phase 3 EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof…
19 May 2015

Editor’s Pick: The Electronic Nose Arises Into the 21st Century

Electronic noses (eNoses) are instruments designed to imitate the sense of smell. These devices are used to detect and precisely distinguish odours…
19 May 2015

Treatment of Isolated Intracranial Progression of Lung Cancer During Treatment with Systemic Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs)

Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are an effective treatment for non-small-cell lung cancer (NSCLC)…
19 May 2015

Frequent Exacerbators in Chronic Obstructive Pulmonary Disease: From Research to Clinical Practice

Acute exacerbations of chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality and contribute to disease progression.
19 May 2015

Nerves, Cough, and Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It has a poor prognosis with a median survival of…